What’s new at CRO

Date
Aug 14, 2018

Completion of recruitment phase for phase I MS trial

Teaser text
Recently we finished recruiting for a Phase I trial in patients with progressive multiple sclerosis. This randomized, double-blind, placebo-controlled study was designed to assess the safety and tolerability of a new biologic as well as the pharmacodynamics...
Date
Jun 23, 2018

MAD/Phase IIa T2D study publication available

Teaser text
As of today you can access a new paper published in The Lancet on 22 June 2018 on a combined multiple-ascending dose (MAD) and Phase IIa study in n=112 patients with controlled type 2 diabetes (HbA1c levels between 6.5–8.5%) via...
Date
Jan 31, 2018

Relocation of Charité Research Organisation's Phase I Unit

Teaser text
In January 2018 CRO’s Phase I unit moved from Campus Virchow-Klinikum (CVK) to Campus Mitte at Charité – Universitätsmedizin Berlin. Located at the very heart of Charité’s historic campus, the new facilities underwent extensive modernisation ...